These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparing FGFR-3 and TS-HDS Seropositive Small Fiber Neuropathy: Unique Patient Features, Symptoms, Laboratory, and Nerve Conduction Study Findings. Murin PJ; Khasiyev F; Profirovic J; Fedorova M; Kafaie J J Clin Neuromuscul Dis; 2024 Jun; 25(4):171-177. PubMed ID: 38771226 [TBL] [Abstract][Full Text] [Related]
8. A double-blind placebo-controlled pilot study of immunoglobulin for small fiber neuropathy associated with TS-HDS and FGFR-3 autoantibodies. Gibbons CH; Rajan S; Senechal K; Hendry E; McCallister B; Levine TD Muscle Nerve; 2023 May; 67(5):363-370. PubMed ID: 36367813 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of Axonal Sensory Neuropathy With IgM Binding to Trisulfated Heparin Disaccharide in Patients With Fibromyalgia. Malik A; Lopate G; Hayat G; Jones J; Atluri R; Malo B; Pestronk A J Clin Neuromuscul Dis; 2019 Mar; 20(3):103-110. PubMed ID: 30801480 [TBL] [Abstract][Full Text] [Related]
10. Autoantibodies Against Trisulfated Heparin Disaccharide and Fibroblast Growth Factor Receptor-3 May Play a Role in the Pathogenesis of Neuropathic Corneal Pain. Bayraktutar BN; Atocha V; Farhad K; Soto O; Hamrah P Cornea; 2023 Jul; 42(7):821-828. PubMed ID: 36256257 [TBL] [Abstract][Full Text] [Related]
11. TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience. Chompoopong P; Rezk M; Mirman I; Berini SE; Dyck PJB; Mauermann M; Shouman K; Klein C; Mills JR; Dubey D J Neurol; 2023 Sep; 270(9):4523-4528. PubMed ID: 37294321 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic plasma exchange for peripheral neuropathy associated with trisulfated heparan disaccharide IgM antibodies: A case series of 17 patients. Olsen GM; Tormey CA; Tseng B; Hendrickson JE; Sostin N J Clin Apher; 2022 Feb; 37(1):13-18. PubMed ID: 34698404 [TBL] [Abstract][Full Text] [Related]
13. Advances in the Management of Small Fiber Neuropathy. Zeidman LA Neurol Clin; 2021 Feb; 39(1):113-131. PubMed ID: 33223078 [TBL] [Abstract][Full Text] [Related]
14. Possible Association Between Anti-Trisulfated-Heparin-Disaccharide (TS-HDS) Immunoglobulin M Autoantibody and Fibromyalgia Syndrome. Nissan J; Blokh A; Ben-Shabat N; Heidecke H; Halpert G; Shoenfeld Y; Amital H Isr Med Assoc J; 2023 Mar; 25(3):187-190. PubMed ID: 36946662 [TBL] [Abstract][Full Text] [Related]
15. Clinical and Laboratory Profiles of Idiopathic Small Fiber Neuropathy in Children: Case Series. Kafaie J; Al Balushi A; Kim M; Pestronk A J Clin Neuromuscul Dis; 2017 Sep; 19(1):31-37. PubMed ID: 28827487 [TBL] [Abstract][Full Text] [Related]
16. IVIg for TS-HDS and FGFR-3 antibody-positive small-fiber neuropathy: A fading signal for efficacy? Katzberg HD; Barnett C Muscle Nerve; 2023 May; 67(5):339-340. PubMed ID: 36762497 [No Abstract] [Full Text] [Related]